Resources
Retinoblastoma genetics screening and clinical management
BMC medical genomics, Vol. 14, Issue 1, Pages 188, 2021
PMID: 34294096
India accounts for 20% of the global retinoblastoma (RB) burden. However, the existing data on RB1 gene germline mutations and its influence on clinical decisions is minimally explored.
https://www.ncbi.nlm.nih.gov/pubmed/34294096
Considering Genomic Research?
Company
Resources
Research
- Tumor Microenvironment Solutions
- Immune Profiling Services
- NGS Services
- BioFX Bioinformatics Services
- Antibody Discovery Services
Diagnostics
Contact
2024 © MedGenome • All Rights Reserved